14-day Premium Trial Subscription Try For FreeTry Free
FRA:DBVA
Delisted

DBV Technologies S.A. Stock Price (Quote)

Frankfurt Stock Exchange > Healthcare > Biotechnology
Open Broker Account
1.27€
-0.140 (-9.93%)
At Close: Apr 18, 2023
Forecast Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days 1.22€ 1.41€ Tuesday, 18th Apr 2023 DBVA.F stock ended at 1.27€. This is 9.93% less than the trading day before Monday, 17th Apr 2023. During the day the stock fluctuated 0% from a day low at 1.27€ to a day high of 1.27€.
90 days 1.00€ 1.45€
52 weeks 0.89€ 3.00€

Historical DBV Technologies S.A. prices

Date Open High Low Close Volume
Sep 24, 2018 20.60€ 20.60€ 20.60€ 20.60€ 0
Sep 21, 2018 20.40€ 20.80€ 20.40€ 20.80€ 400
Sep 20, 2018 20.40€ 20.40€ 20.40€ 20.40€ 0
Sep 19, 2018 20.60€ 20.60€ 20.60€ 20.60€ 0
Sep 18, 2018 20.40€ 20.40€ 20.40€ 20.40€ 0
Sep 17, 2018 20.20€ 20.20€ 20.20€ 20.20€ 0
Sep 14, 2018 19.90€ 19.90€ 19.90€ 19.90€ 0
Sep 13, 2018 19.70€ 19.70€ 19.70€ 19.70€ 0
Sep 12, 2018 18.90€ 18.90€ 18.90€ 18.90€ 0
Sep 11, 2018 19.00€ 19.00€ 19.00€ 19.00€ 0
Sep 10, 2018 18.80€ 18.80€ 18.80€ 18.80€ 0
Sep 07, 2018 18.20€ 18.20€ 18.20€ 18.20€ 0
Sep 06, 2018 18.40€ 18.40€ 18.40€ 18.40€ 0
Sep 05, 2018 18.40€ 18.40€ 18.40€ 18.40€ 0
Sep 04, 2018 19.00€ 19.00€ 19.00€ 19.00€ 0
Sep 03, 2018 19.00€ 19.00€ 19.00€ 19.00€ 0
Aug 31, 2018 18.80€ 18.80€ 18.80€ 18.80€ 0
Aug 30, 2018 18.80€ 18.80€ 18.80€ 18.80€ 0
Aug 29, 2018 18.70€ 18.70€ 18.70€ 18.70€ 0
Aug 28, 2018 18.60€ 18.60€ 18.60€ 18.60€ 0
Aug 27, 2018 18.30€ 18.30€ 18.30€ 18.30€ 0
Aug 24, 2018 18.20€ 18.20€ 18.20€ 18.20€ 0
Aug 23, 2018 17.80€ 17.80€ 17.80€ 17.80€ 0
Aug 22, 2018 17.60€ 17.60€ 17.60€ 17.60€ 34
Aug 21, 2018 16.50€ 16.50€ 16.50€ 16.50€ 0
Click to get the best stock tips daily for free!

About DBV Technologies S.A.

DBV Technologies S.A. DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical t... DBVA.F Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT